|
A Phase III Study of Entecavir vs Lamivudine in Adults with Chronic Hepatitis B Infection and Positive for Hepatitis B E Antigen Clinical Trials Resources presented on Clinical Trials Search is not meant to be a substitute for proven health advice, calls or treatment with a real medical. We aren't mDs. Always consult your doctor on A Phase III Study of Entecavir vs Lamivudine in Adults with Chronic Hepatitis B Infection and Positive for Hepatitis B E Antigen conditions. Clinical Trials Search.org is a website dedicated to listing clinical research studies in human subjects. A Phase III Study of Entecavir vs Lamivudine in Adults with Chronic Hepatitis B Infection and Positive for Hepatitis B E Antigen Clinical research trials and A Phase III Study of Entecavir vs Lamivudine in Adults with Chronic Hepatitis B Infection and Positive for Hepatitis B E Antigen healthcare trials take place in a lot of of localities throughout the U.S.. A clinical trial or clinical study is a research project with human volunteer subjects. Clinical drug trials and pharmaceutical clinical trials typically assess the effectiveness of new does drugs. The function of the studies / projects is to figure out specific human medical questions. Clinical trials are a popular means for doctors, government agencies, and private sector corporations to find cures for all varieties of conditions, like A Phase III Study of Entecavir vs Lamivudine in Adults with Chronic Hepatitis B Infection and Positive for Hepatitis B E Antigen. A Phase III Study of Entecavir vs Lamivudine in Adults with Chronic Hepatitis B Infection and Positive for Hepatitis B E Antigen Clinical Trials and other clinical trials allow volunteers to access health treatment options before they are available to the masses. Many times the subjects receive professional assistance for free, and every now and again they are compensated for their time. Sometimes there is a cost for a A Phase III Study of Entecavir vs Lamivudine in Adults with Chronic Hepatitis B Infection and Positive for Hepatitis B E Antigen clinical trial. Human subjects often obtain the finest healthcare possible for their A Phase III Study of Entecavir vs Lamivudine in Adults with Chronic Hepatitis B Infection and Positive for Hepatitis B E Antigen condition. Hazards are a reality, nevertheless, and might include additional or frequent dr. calls, health hazards (potentially life-jeopardizing), and/or the treatment being uneffective. Trials are federally regulated with stern guidelines to protect clinical trials patients.
|
|
|
|
|
|
|
Home > "A" Clinical Trials Conditions > A Phase III Study of Entecavir vs Lamivudine in Adults with Chronic Hepatitis B Infection and Positive for Hepatitis B E Antigen  A Phase III Study of Entecavir vs Lamivudine in Adults with Chronic Hepatitis B Infection and Positive for Hepatitis B E Antigen
A Phase III Study of Entecavir vs Lamivudine in Adults with Chronic Hepatitis B Infection and Positive for Hepatitis B E Antigen
For Condition: Chronic Hepatitis B
Status: No longer recruiting
Sponsor(s): Bristol-Myers Squibb ,
Synopsis: The purpose of this clinical research study is to assess the safety effectiveness of entecavir, as compared to lamivudine, in the treatment of adults with chronic hepatitis B infection who are hepatitis B e antigen positive.
Details:
Eligibility:
Study Type: Interventional, Treatment
Minimum Age/Maximum Age: 16 Years/
Genders: Both
Protocol Entry Criteria: - Male and female subjects =/> 16 years of age (or minimum age required in a given country) with history of chronic hepatitis B infection; - Documentation of positive Hepatitis B e antigen (HBeAg) status.; - The absence of coinfection with immunodeficiency virus (HIV), hepatitis C virus (HCV) or hepatitis D virus (HDV); - The absence of other forms of liver disease e.g., alcoholic, autoimmune, biliary disease; - Less than 12 weeks prior therapy with nucleoside or nucleotide analogue antiviral agents with activity against hepatitis B (e.g., adefovir, famciclovir and lamivudine)
Total Enrollment:
Location and Contact Information:
Local Investigator
Farmington, Connecticut, 06030
United States
Local Investigator
St. Paul, Minnesota, 55114
United States
Local Investigator
Worcester, Massachusetts, 01655
United States
Local Investigator
Tucson, Arizona, 85724
United States
Local Investigator
Chicago, Illinois, 60622
United States
Local Investigator
Rochester, New York, 14642
United States
Local Investigator
New York City, New York, 10032
United States
Local Investigator
Richmond, Virginia, 23249
United States
Local Investigator
Los Angeles, California, 90048
United States
Local Investigator
Ann Arbor, Michigan, 48109
United States
Local Investigator
New York City, New York, 10029
United States
Local Investigator
Palo Alto, California, 94304
United States
Local Investigator
Seattle, Washington, 98195
United States
Local Investigator
Pittsburgh, Pennsylvania, 15213
United States
Local Investigator
Torrance, California, 90505
United States
Local Investigator
Atlanta, Georgia, 30309
United States
Local Investigator
Atlanta, Georgia, 30322
United States
Local Investigator
Boston, Massachusetts, 02111
United States
Local Investigator
Cleveland, Ohio, 44125
United States
Local Investigator
Fairfax, Virginia, 22031
United States
Local Investigator
Iowa City, Iowa, 52242
United States
Local Investigator
Miami, Florida, 33136
United States
Local Investigator
Philadelphia, Pennsylvania, 19104
United States
Local Institution
San Francisco, California, 94115
United States
Local Investigator
Birmingham, Alabama, 35294
United States
Local Investigator
La Jolla, California, 92037
United States
Local Investigator
Orange, California, 92868
United States
Investigator Meeting
Providence, Rhode Island, 02908
United States
Local Investigator
Dallas, Texas, 75235
United States
Local Investigator
Royal Oak, Michigan, 48073
United States
Local Investigator
Charlotte, North Carolina, 28203
United States
Local Investigator
Nashville, Tennessee, 37211
United States
Local Investigator
New York City, New York, 10003
United States
Local Investigator
Honolulu, Hawaii, 96820
United States
Local Investigator
Manhasset, New York, 11030
United States
Additional Information:
Study ID Numbers: AI463-022;
Study Start Date:
Record last reviewed: February 2004
Additional information available at: clinicaltrials.gov
Clinicaltrials.gov Reference link: NCT00035633
Other Chronic Hepatitis B Studies:
1. An Open-Label Program of Adefovir Dipivoxil in the Treatment of Patients with Lamivudine-Resistant Chronic Hepatitis B With Limited Treatment Options
2. Lamivudine for Chronic Hepatitis B
3. Safety and antiviral study of ACH126, 433 (b-L-Fd4C) in adults with lamivudine-resistant chronic hepatitis B
4. Evaluate Efficacy, Safety and PK of Adefovir Dipivoxil Liquid Suspension in Patients with Chronic Hepatitis B
5. Lamivudine and Adefovir to Treat Chronic Hepatitis B Infection in People With and Without HIV Infection
Related Studies:
Other Chronic Hepatitis B Clinical Trials
Other California Clinical Trials
Other Los Angeles Clinical Trials
A Phase III Study of Entecavir vs Lamivudine in Adults with Chronic Hepatitis B Infection and Positive for Hepatitis B E Antigen
|
|
|
|
|
|
|
|
